LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-edge treatments A2A Pharmaceuticals focuses on developing novel therapeutics for cancer and antibiotic-resistant bacterial infections, presenting opportunities to collaborate or partner with medical institutions and research organizations.

AI-driven rare diseases The recent partnerships with Insilico Medicine reveal a strategic emphasis on leveraging AI for rare disease treatments, indicating potential avenues for joint projects or knowledge exchange with AI-driven companies in the healthcare sector.

Financial growth potential Despite currently no disclosed funding, A2A Pharmaceuticals operates in the revenue range of $0-$10M, suggesting potential sales opportunities for service providers or vendors targeting mid-size pharmaceutical companies in the oncology and antibiotic research space.

Tech-enabled drug discovery The tech stack utilized by A2A Pharmaceuticals includes cutting-edge tools like Webpack and Lodash, indicating a reliance on advanced technology for drug discovery. This presents opportunities for tech solution providers looking to cater to pharmaceutical research firms.

Strategic partnerships The launch of Consortium.AI and multiple collaborations with Insilico Medicine signal A2A Pharmaceuticals' interest in strategic alliances. This hints at potential sales opportunities for companies offering complementary AI-driven technologies or research capabilities.

Similar companies to A2A Pharmaceuticals

A2A Pharmaceuticals Tech Stack

A2A Pharmaceuticals uses 8 technology products and services including Google Font API, TweenMax, RequireJS, and more. Explore A2A Pharmaceuticals's tech stack below.

  • Google Font API
    Font Scripts
  • TweenMax
    Javascript Frameworks
  • RequireJS
    Javascript Frameworks
  • Zepto
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • Polyfill
    Javascript Libraries
  • Webpack
    Miscellaneous
  • reCAPTCHA
    Security

A2A Pharmaceuticals's Email Address Formats

A2A Pharmaceuticals uses at least 2 format(s):
A2A Pharmaceuticals Email FormatsExamplePercentage
FLast@a2apharma.netJDoe@a2apharma.net
71%
Last@a2apharma.netDoe@a2apharma.net
29%

Frequently Asked Questions

What is A2A Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
A2A Pharmaceuticals's official website is a2apharma.com and has social profiles on LinkedIn.

How much revenue does A2A Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of August 2024, A2A Pharmaceuticals's annual revenue reached $750K.

What is A2A Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
A2A Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does A2A Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of August 2024, A2A Pharmaceuticals has approximately 10 employees across 2 continents, including North AmericaEurope. Key team members include Chief Strategy Officer & Executive Vice President (r&d): S. V.Chief Scientific Officer: C. L.Vice President Of Clinical Operations: R. F.. Explore A2A Pharmaceuticals's employee directory with LeadIQ.

What industry does A2A Pharmaceuticals belong to?

Minus sign iconPlus sign icon
A2A Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does A2A Pharmaceuticals use?

Minus sign iconPlus sign icon
A2A Pharmaceuticals's tech stack includes Google Font APITweenMaxRequireJSZeptoLodashPolyfillWebpackreCAPTCHA.

What is A2A Pharmaceuticals's email format?

Minus sign iconPlus sign icon
A2A Pharmaceuticals's email format typically follows the pattern of . Find more A2A Pharmaceuticals email formats with LeadIQ.

When was A2A Pharmaceuticals founded?

Minus sign iconPlus sign icon
A2A Pharmaceuticals was founded in 2016.
A2A Pharmaceuticals

A2A Pharmaceuticals

Pharmaceutical Manufacturing2-10 Employees

A2A Pharmaceuticals designs computationally optimized small molecule therapeutics for the treatment of cancer and antibiotic resistant bacterial infections.  Our two oncology programs are focused on inhibiting essential protein-protein interactions in leukemia and in diverse solid tumors. These interactions are critical for cancer progression, but non-essential in normal cells. The antibiotic programs target biosynthetic enzymes in gram-negative bacteria, in pathways not found in humans. The targets selected have no clinically used therapeutics, minimizing susceptibility to resistance; and unlike the numerous follow-on antibiotics currently in development. 


Our approach integrates interdisciplinary ingenuity with computational tools to design new drug candidates using our proprietary SCULPT platform. Experimentally determined target characteristics guide the selection and placement of fragments to recapitulate key contact points of proteins and/or ligands known to bind. Fragments are incorporated into the target-specific construction of combinatorial in silico libraries, which are designed based on synthetic feasibility. Libraries consisting of thousands to millions of small molecules are iteratively built, and computationally evaluated for potency and optimal ADMET properties. The final selection is made from dozens of iterations, totaling upwards of 100 million compounds.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2016
Employees
2-10

Section iconFunding & Financials

  • $10M

    A2A Pharmaceuticals's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    A2A Pharmaceuticals's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.